Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 8/19/2020CDE Solicits Comments on the Draft Technical Guidance for Bioequivalen...
  • 8/14/2020CDE Solicits Comments on the Draft Technical Guidelines for Similarity...
  • 8/12/2020NMPA Issues 2019 Drug Regulatory Statistics Annual Report
  • 8/11/2020CDE Publicizes Video and PPT Info of Latest Symposium on GQCE of Chemi...
  • 8/10/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...
  • 8/10/2020CDE Solicits Comments on Chinese Translation of ICH M7 Q&A and...
  • 8/7/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical P...
  • 8/6/2020CDE Issues the Filing Requirements and Procedures for Sub-packaging of...
  • 8/6/2020NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...
  • 8/6/2020NMPA Solicits Comments on the Draft Interim Rules for Domestic Agents ...
  • 8/5/2020CDE Seeks Feedbacks on Draft Requirements for Application Dossiers of ...
  • 8/3/2020CDE Solicits Comments on the Guidance Principles on Real World Data Us...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines for Model-led Drug R...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines for Population Pharm...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines on Bioequivalence St...
  • 8/3/2020CDE Solicits Comments on the Guidelines for Research and Validation of...
  • 8/3/2020NMPA Issues the Guidelines for Clinical Trials of Bevacizumab and Adal...
  • 8/3/2020NMPA Solicits Comments on the Rules of Post Marketing Changes of Drug ...
  • 8/1/2020Review of Chinese Drug Evaluation and Registration in 2019
  • 7/31/2020NMPA Suspends Import of Sanyo Chemical's Methoxyphenamine
  • 7/31/2020CDE Solicits Comments on Four Draft Technical Guidelines
  • 7/30/2020NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...
  • 7/30/2020NMPA Issues Policy for Further Strengthening the ADR Monitoring and Ap...
  • 7/29/2020CDE Solicits Comments on Chinese Translation of ICH S5(R3) and S11
  • 7/24/2020CDE Solicits Comments on the Draft Technical Guidelines for Pharmacy S...
  • 7/24/2020CDE Issues the Guidelines for Non-inferiority Design of Drug Clinical ...
  • 7/22/2020NMPA Announces OTC Switch of Two Prescription Drugs
  • 7/21/2020NMPA Issues Announcement for Applicability of ICH E2C(R2)
  • 7/20/2020CDE Issues the Clinical Research Guidelines for Rituximab Biosimilar
  • Page:3/9 Total number of articles:247: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group Support by: www.heightow.com